These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35974795)

  • 1. Development of prognostic models for survival and care status in sporadic Creutzfeldt-Jakob disease.
    Nihat A; Ranson JM; Harris D; McNiven K; Mok T; Rudge P; Collinge J; Llewellyn DJ; Mead S
    Brain Commun; 2022; 4(4):fcac201. PubMed ID: 35974795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic background of human prion diseases].
    Kovács GG
    Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.
    Mead S; Burnell M; Lowe J; Thompson A; Lukic A; Porter MC; Carswell C; Kaski D; Kenny J; Mok TH; Bjurstrom N; Franko E; Gorham M; Druyeh R; Wadsworth JD; Jaunmuktane Z; Brandner S; Hyare H; Rudge P; Walker AS; Collinge J
    JAMA Neurol; 2016 Apr; 73(4):447-55. PubMed ID: 26902324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
    Samman I; Schulz-Schaeffer WJ; Wöhrle JC; Sommer A; Kretzschmar HA; Hennerici M
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):678-81. PubMed ID: 10519881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene.
    Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M
    Prion; 2014; 8(5):336-8. PubMed ID: 25495585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
    Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
    BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene.
    Marcon G; Indaco A; Di Fede G; Suardi S; Finato N; Moretti V; Micoli S; Fociani P; Zerbi P; Pincherle A; Redaelli V; Tagliavini F; Giaccone G
    Brain Pathol; 2014 Mar; 24(2):148-51. PubMed ID: 24118545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective 10-year surveillance of human prion diseases in Japan.
    Nozaki I; Hamaguchi T; Sanjo N; Noguchi-Shinohara M; Sakai K; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Moriwaka F; Shiga Y; Kuroiwa Y; Nishizawa M; Kuzuhara S; Inuzuka T; Takeda M; Kuroda S; Abe K; Murai H; Murayama S; Tateishi J; Takumi I; Shirabe S; Harada M; Sadakane A; Yamada M
    Brain; 2010 Oct; 133(10):3043-57. PubMed ID: 20855418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease.
    Kovacs GG; Head MW; Bunn T; Laszlo L; Will RG; Ironside JW
    Neuropathol Appl Neurobiol; 2000 Oct; 26(5):463-72. PubMed ID: 11054187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.
    Ito Y; Sanjo N; Hizume M; Kobayashi A; Ohgami T; Satoh K; Hamaguchi T; Yamada M; Kitamoto T; Mizusawa H; Yokota T
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1055-1061. PubMed ID: 29382530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.
    Bishop MT; Pennington C; Heath CA; Will RG; Knight RS
    BMC Med Genet; 2009 Dec; 10():146. PubMed ID: 20035629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development.
    Mitrová E; Belay G
    Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein codon 129 polymorphism in mild cognitive impairment and dementia: the Rotterdam Study.
    Karamujić-Čomić H; Ahmad S; Lysen TS; Heshmatollah A; Roshchupkin GV; Vernooij MW; Rozemuller AJM; Ikram MA; Amin N; van Duijn CM
    Brain Commun; 2020; 2(1):fcaa030. PubMed ID: 32954288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification.
    Bougard D; Bélondrade M; Mayran C; Bruyère-Ostells L; Lehmann S; Fournier-Wirth C; Knight RS; Will RG; Green AJE
    Emerg Infect Dis; 2018 Jul; 24(7):1364-1366. PubMed ID: 29912702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic model for overall survival in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Rübsamen N; Hermann P; Schmitz M; Villar-Piqué A; Goebel S; Karch A; Zerr I
    Alzheimers Dement; 2020 Oct; 16(10):1438-1447. PubMed ID: 32614136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.